Stay updated on CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Sign up to get notified when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision bumped from v3.0.1 to v3.0.2; 'Back to Top' was removed. No changes to pricing, stock, or names.
    Difference
    0.6%
    Check dated 2025-09-14T23:10:31.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.6%
    Check dated 2025-09-07T19:47:14.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries.
    Difference
    33%
    Check dated 2025-08-31T12:34:23.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.16.11 to v2.16.12 and changed the date from 2025-05-14 to 2025-08-12.
    Difference
    1.0%
    Check dated 2025-08-17T05:06:27.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-10T00:49:19.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:03:22.000Z thumbnail image

Stay in the know with updates to CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Enter your email address, and we'll notify you when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.